Inside EU Health Inside EU Health: EFPIA compares 10 biopharma strategies; EU cancer strategy scrutinised; agencies reassure on infant formula EFPIA publishes a comparative analysis of the strategies of 10 countries; ECA casts doubt on EU cancer strategy’s targets and funding; agencies says infant formula is a low risk following recall
Infant formula EU agencies consider risk of exposure low, as recall of infant formula continues EU agencies consider risk from contaminated infant formula be to low as recall continues
AMR Persistent antimicrobial resistance in the food chain underlines need for a ‘One Health’ approach Antimicrobial resistance in common foodborne bacteria poses a threat to Europe’s public health, despite pockets of progress
Inside EU Health Inside EU Health: Europe invests in 10-year preparedness research plan; Biotech Act I rapporteurs; EU and Canada health agencies joint plan; HTA report Europe invests €240 million ten-year pandemic preparedness research; Biotech Act I rapporteurs confirmed; EU and Canada health agencies deepen ties; HTA annual report on first year of implementation
Measles 8 in 10 people who fell ill with measles during 2025 had not been vaccinated 80% of measles cases in 2025 occurred among unvaccinated people underscoring the importance of vaccination
Inside EU Health Inside EU Health: A strategy for women’s health; Winter Olympics 2026; EIB support for health Fifty groups present demand for a new approach to women’s health; ECDC offers health tips to those attending the Winter Olympics 2026; EIB activity report says 18.4 million benefited from improved health services
Inside EU Health Inside EU Health: EPP request pause on wastewater law; S&D urges Várhelyi to back €90 billion for health in next MFF; infant formula recall; ERC backs bench-to-clinic innovations; WHO inaugurates Cyprus office Várhelyi sympathetic to one-year ‘stop-the-clock’ pause; S&D urges Várhelyi to back €90 billion for health in next MFF; ECDC warns of toxin-containing infant formula; ERC backs bench-to-clinic innovations; WHO/Europe establishes Cyprus office
Inside EU Health Inside EU Health: US tariffs and MFN pricing threaten EU investment and access; EMA and FDA agree good AI; ECDC issues warning on Doxy-PEP Inside EU Health: US tariffs and MFN pricing threaten EU investment and access; EMA and FDA agree good AI principles; ECDC issues warning on Doxy-PEP
Listeria Listeria remains Europe's most lethal foodborne threat ECDC and EFSA warn over danger of Listeria and Salmonella in latest One Health report
Avian influenza High levels of avian influenza increase the risk to humans The European Centre for Disease Prevention and Control (ECDC) has raised concern that the elevated level of avian influenza poses a greater risk of human exposure
Inside EU Health Inside EU Health: ECDC calls for uptake of flu vaccination; the UK concludes part two of Covid inquiry; vaccines and the fight against AMR ECDC urges immediate uptake of flu vaccination; ‘too little, too late’ - the UK concludes the second report of the Covid inquiry; vaccines and the fight against AMR
Seasonal influenza ECDC urges immediate uptake of flu vaccination The European Centre for Disease Prevention and Control (ECDC) is calling for immediate influenza vaccination as EU/EEA countries report an unusually early rise in flu cases
AMR Europe not on track to meet four of five AMR targets New data from the ECDC shows the threat of antimicrobial resistance, known as ‘the silent killer’, continues to rise across the EU
ECDC ECDC marks 20 years of operation and looks to future threats The European Centre for Disease Prevention and Control reflects on two decades of crisis response and looks ahead to emerging threats
AMR WHO warns of alarming rise in antimicrobial resistance - Europe is not immune The WHO’s 2025 report on antimicrobial resistance warns of accelerating global threats and widening treatment gaps
AMR ECDC calls for urgent action on the spread of drug-resistant fungus The European Centre for Disease Prevention and Control (ECDC) has issued a warning about the continued spread of Candidozyma auris (C. auris) in European hospitals. C. auris is a species of yeast that was designated as a priority fungal pathogen by the World Health Organization in 2022. First discovered in
